Virax Biolabs Group Ltd (VRAX) AI Dilution Summary

Cash was $6,438,909 at 2026-03-31 against estimated monthly burn of $385,158. The company is funding itself through its active H.C. Wainwright ATM, authorised to $2,070,060.20, with 138,901 shares sold since the program began; ATM sales through 2026-09-04 are the most recent capital raised, and sales after 2026-09-04 are not yet reported. Dilution here is driven primarily by that ATM's $2,070,060.20 of remaining capacity.